-+ 0.00%
-+ 0.00%
-+ 0.00%
/C O R R E C T I O N -- Bridge to Life, Ltd./
Share
Listen to the news

DULUTH, Ga, and LONDON, Aug. 27, 2026 /PRNewswire/ -- Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of new HealthTech guidance by the United Kingdom's National Institute for Health and Care Excellence (NICE),  recommending routine National Health Service (NHS) funding for ex-situ machine perfusion devices, including Bridge to Life's VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, to preserve deceased donor livers for transplantation.

Read more at prnewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending